Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis

BACKGROUND: Systemic hypertension often accompanies chronic renal failure and can accelerate its progression to end-stage renal disease (ESRD). Adjunctive moxonidine appeared to have benefits versus adjunctive nitrendipine, in a randomised double-blind six-month trial in hypertensive patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Littlewood, Kavi J, Greiner, Wolfgang, Baum, Dominique, Zoellner, York
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976090/
https://www.ncbi.nlm.nih.gov/pubmed/17645811
http://dx.doi.org/10.1186/1471-2369-8-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976090/
https://www.ncbi.nlm.nih.gov/pubmed/17645811
http://dx.doi.org/10.1186/1471-2369-8-9

Ejemplares similares